Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm
NCT06545344 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2025-06-29
Summary
This clinical trial evaluates a palliative care consultation for improving communication between providers and patients considering surgery for a pancreatic neoplasm. Pancreatic operations have known complications that can affect quality of life. Palliative care has been shown to improve patient reported quality of life and functional outcomes. Receiving a palliative care consultation may improve communication and decision making for patients considering surgery for a pancreatic neoplasm.
Conditions
- Pancreatic Neoplasm
Interventions
- OTHER
-
Best Practice
Receive usual care
- PROCEDURE
-
Palliative Care Consultation
Attend a palliative care visit
- OTHER
-
Survey Administration
Ancillary studies
- OTHER
-
Tumor Board Review
Undergo evaluation by tumor board
Sponsors & Collaborators
-
Fred Hutchinson Cancer Center
lead OTHER
Principal Investigators
-
Elizabeth Loggers · Fred Hutch/University of Washington Cancer Consortium
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-01
- Primary Completion
- 2026-01-01
- Completion
- 2026-01-01
Countries
- United States
Study Locations
More Related Trials
-
Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
NCT00049348 ·Status: COMPLETED ·Phase: PHASE2
-
Perioperative Therapy for Resectable Pancreatic Cancer
NCT00609336 ·Status: COMPLETED ·Phase: PHASE2
-
Integrating Palliative Care and Modern Palliative Care Tools Into the Care of Patients With Pancreas Cancer
NCT01784081 ·Status: WITHDRAWN
-
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
NCT01240304 ·Status: TERMINATED ·Phase: PHASE2
-
Early Palliative Care for Patients With Advanced Pancreatic Cancer.
NCT04632303 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study
NCT02782182 ·Status: TERMINATED ·Phase: PHASE1
-
Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer
NCT00003332 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Distal Pancreatectomy With Partial Splenectomy for Pancreatic Tumors
NCT01412684 ·Status: WITHDRAWN
-
Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery
NCT04452461 ·Status: RECRUITING ·Phase: PHASE2
-
Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer
NCT00902733 ·Status: COMPLETED ·Phase: NA
-
Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer
NCT02243007 ·Status: TERMINATED ·Phase: PHASE2
-
Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma
NCT02754726 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer
NCT00026403 ·Status: COMPLETED ·Phase: PHASE2
-
Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")
NCT01726582 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Evaluation of Multi-modality Algorithm for Non-metastatic Adenocarcinoma of Pancreas or Ampulla
NCT02626520 ·Status: TERMINATED ·Phase: PHASE2
-
A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma
NCT01660711 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
NCT02580422 ·Status: TERMINATED
-
Changes in Muscle Tissue in Patients With Pancreatic Cancer
NCT00369460 ·Status: COMPLETED
-
Chemoradiation in Locally Advanced Pancreatic Cancer
NCT00262951 ·Status: TERMINATED ·Phase: PHASE2
-
Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
NCT00112697 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer
NCT01821612 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas
NCT02595424 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Impact of Pancreatic Endoscopic Drainage on Exocrine Pancreatic Function in Unresectable Pancreatic Cancer
NCT05244174 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer
NCT01851174 ·Status: TERMINATED ·Phase: PHASE2
-
Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery
NCT00335543 ·Status: COMPLETED ·Phase: PHASE2